# Studies of Neuregulin/ERBB Signaling in Human Heart

> **NCT02820233** · — · RECRUITING · sponsor: **Douglas B. Sawyer** · enrollment: 80 (estimated)

## Conditions studied

- Heart Disease
- Vascular Disease
- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02820233
- **Lead sponsor:** Douglas B. Sawyer
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2015-06
- **Primary completion:** 2028-09
- **Final completion:** 2029-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02820233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02820233, "Studies of Neuregulin/ERBB Signaling in Human Heart". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02820233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*